Advanced Search
MyIDEAS: Login

The Case of the Detrimental Drug: Implications for the Stakeholder Theory of Directorship

Contents:

Author Info

  • JS Armstrong

    (The Wharton School - University of Pennsylvania)

Abstract

The Winter 1979 issues of Directors and Boards presented readers with a questionnaire based to a degree on a 1969 board incident at Upjohn Corporation [see Box 1 (on page 2) and Box 2 (on pages 3-4)]. In this questionnaire, a profitable drug named “Wondola” was being produced by the so-called International Drug Corporation (IDC). Readers were told that members of the American Medical Association's Council on Drugs had objected to the sale of most fixed -ratio (combination) drugs on the grounds that they grant no benefits superior to those of single- ingredient drugs, and are more likely to produce detrimental side effects, including death. Wondola, with an approximated fatality record of 14 to 22 deaths per year, was no exception. The Federal Drug Administration had asked IDC to withdraw the drug. Readers were asked how they would have voted at a board meeting called to resolve the withdrawal issue. Several months after the publication of the first questionnaire, follow-up questionnaires were sent to D&B readers and to select corporate constituents. These letters solicited comments on a “stakeholder” theory of board membership which I proposed in conjunction with the Wondola experiment. In the following pages, I present the background of the experiment. The stakeholder theory will then be proposed as a solution to the “responsiblity dilemma” the Wondola case raises. Finally, questionnaire respondents will speak for themselves on this complex issue.

Download Info

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
File URL: http://128.118.178.162/eps/get/papers/0412/0412030.pdf
Download Restriction: no

Bibliographic Info

Paper provided by EconWPA in its series General Economics and Teaching with number 0412030.

as in new window
Length: 19 pages
Date of creation: 10 Dec 2004
Date of revision:
Handle: RePEc:wpa:wuwpgt:0412030

Note: Type of Document - pdf; pages: 19
Contact details of provider:
Web page: http://128.118.178.162

Related research

Keywords: stakeholder theory; responsiblity dilemma; drug;

Other versions of this item:

Find related papers by JEL classification:

This paper has been announced in the following NEP Reports:

References

No references listed on IDEAS
You can help add them by filling out this form.

Citations

Lists

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

Statistics

Access and download statistics

Corrections

When requesting a correction, please mention this item's handle: RePEc:wpa:wuwpgt:0412030. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (EconWPA).

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.